Advocacy intelligence hub — real-time data for patient organizations
Swiss Tropical & Public Health Institute — PHASE3
Swiss Tropical & Public Health Institute — PHASE3
Insud Pharma — PHASE3
Kirby Institute — PHASE4
Zero Point Five Therapeutics — PHASE3
Leiden University Medical Center — NA
Baylor College of Medicine — PHASE1
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
VERMOX 500 mg chewable tablets
Janssen Pharmaceutical Research & Development, LLC
VERMOX 500 mg chewable tablets
(mebendazole)Orphan drugstandardJanssen Pharmaceutical Research & Development, LLC
Anthelmintic [EPC]
12.1 Mechanism of Action Mebendazole, a benzimidazole, is an anthelmintic [see Microbiology (12.4) ] .
Nilanthi R de Silva, MD
Faculty of Medicine, University of Kelaniya, Sri Lanka
David Diemert, MD
George Washington University
📍 WASHINGTON, DC
Jennifer Keiser, PhD, LCSW
Swiss Tropical & Public Health Institute
📍 SURPRISE, AZ
Ayola Adegnika, MD
Centre de Recherches Medicales de Lambaréné
David J Diemert, MD
George Washington University
📍 WASHINGTON, DC
Gary Simon, M.D., Ph.D
George Washington University